4.2 Abstract in Atti di convegno: [685] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1 a 20 di 685
Titolo Data di pubblicazione Autore(i) File
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 1-gen-2019 Amodio, V; Grmano, G; Barault, L; Lamba, S; Rospo, G; Magri, A; Maione, F; Crisafulli, G; Cancelliere, C; Lerda, G; Bartolini, A; Siravegna, G; Mussolin, B; Frappolli, R; Montone, M; Randon, G; de Braud, F; Angelozzi, Na; Marsoni, S; D'Incalci, M; Orlandi, A; Giraudo, E; Satore-Bianchi, A; Siena, S; Pietrantonio, F; Di Nicolantonio, F; Bardelli, A
microRNA-181a plays a critical role in ovarian cancer progression through the regulation of epithelial-mesenchymal transition 1-gen-2013 Parikh, A; Lee, C; Joseph, P; Marchini, S; Baccarini, A; Kolev, V; Romualdi, C; Fruscio, R; Shah, H; Feng, W; Mullokandov, G; Fishman, D; D'Incalci, M; Rahaman, J; Kalir, T; Redline, R; Brown, Bd; Narla, G; Difeo, A
In vitro Cytotoxic Effect of Trabectedin on JMML AND CMML Cell Populations 1-gen-2014 Algeri, M; Rosti, V; Zecca, M; Erba, E; Aronica, A; Galli, A; Zambelli, A; Strocchio, L; Tolva, A; Quartuccio, G; Mina, T; D'Incalci, M; Della Porta, Mg
Lurbinectedin (PM01183): Antineoplastic Activity in Murine and Human Experimental Models 1-gen-2012 Fraoolli, R; Bello, E; Zangarini, M; Zucchetti, P; Aviles, P; D'Incalci, M
HMGA1 is a new biomarker of liposarcoma progression 1-gen-2017 Loria, R; Laquintana, V; Bon, G; Trisciuoglio, D; Covello, R; Amoreo, Ca; Ferraresi, V; Zoccali, C; D'Incalci, M; Biagini, R; Falcioni, R
Alpha 1 acid glycoprotein (AGP) binds to STI571 and substantially alters its pharmacokinetics in chronic myeloid leukemia (CML) patients 1-gen-2001 Gambacorti-Passeri, C; Zucchetti, M; Frapolli, R; Russo, D; Rossi, F; Pogliani, E; Corneo, G; Tornaghi, L; Alberti, D; D'Incalci, M
Evaluation of the pan-BET-bromodomain inhibitor OTX015 as a single agent and in combination with everolimus (RAD001) in triple-negative breast cancer 1-gen-2014 Vazquez, R; Astorgues-Xerri, L; Riveiro, Me; Di Marino, M; Beltrame, L; Bekradda, M; Cvitkovic, E; Erba, E; Frapolli, R; D'Incalci, M
SAFETY PROFILE AND TOLERABILITY OF 'TRABECTEDIN AND INDOLE-3-CARBINOL COMBINATION IN REFRACTORY ADVANCED BREAST CANCER. PRELIMINARY RESULTS OF PHASE 1 CLINICAL STUDY 1-gen-2013 Tancredi, R; Negri, S; Cattrini, C; Ponchio, L; Frascaroli, M; Daprada, G; Fregoni, V; Pavesi, L; Riccardi, A; Zucchetti, M; D'Incalci, M; Zambelli, A
Activity and safety of trabectedin in patients with sarcomatoid / biphasic malignant pleural mesothelioma (MPM) 1-gen-2015 Cortinovis, Dl; Hollander, Lh; Floriani, Ic; Grosso, F; Marinello, A; Ceresoli, Gl; Pacchetti, I; Zucali, Pa; D'Incalci, M; Canova, S; Abbate, Mi; Ugo, F; Vukcaj, S; Bidoli, P
miRNA landscape analysis of stage I EOC, identifies miR-199a-5p associated to poor prognosis in grade 3 subgroup 1-gen-2013 Calura, E; Fruscio, R; Paracchini, L; Bignotti, E; Martini, P; Ravaggi, A; Di Marino, M; Sales, G; Beltrame, L; Dell'Orto, F; Baldo, R; Pecorelli, S; Sartori, E; Zanotti, L; Katsaros, D; Tognon, G; D'Incalci, M; Romualdi, C; Marchini, S
EPOC-experiences - conducting a multinational clinical trial on the pharmacology of doxorubicin in children with cancer 1-gen-2013 Krischke, M; Andre, N; Boddy, A; Bode, G; D'Incalci, M; Hempel, G; Kontny, N; Steel, A; Voller, V; Boos, J
Pharmacokinetics of concomitant cisplatin and paclitaxel administration by hyperthermic intraperitoneal chemotherapy (HIPEC) to patients with peritoneal carcinomatosis 1-gen-2013 Ansaloni, L; Busci, Lm; Coccolini, F; Grosso, G; Lotti, M; Morosi, L; Poiasina, E; Zucchetti, M; D'Incalci, M; Frigerio, L
RANDOMIZED, NON-COMPARATIVE, PHASE II TRIAL OF BEVACIZUMAB AND TRABECTEDIN WITH OR WITHOUT CARBOPLATIN IN PARTIALLY PLATINUM-SENSITIVE OVARIAN CANCER (ROC) WOMEN 1-gen-2017 Colombo, N; Nicoletto, Mo; Lissoni, A; Scambia, G; Tognon, G; Negri, E; Galli, F; Biagioli, E; Rulli, E; Fossati, R; D'Incalci, M
AN OPEN-LABEL, RANDOMIZED PHASE II STUDY ON TRABECTEDIN AND BEVACIZUMAB WITH OR WITHOUT CARBOPLATIN IN PARTIALLY PLATINUM-SENSITIVE (PPS) OVARIAN CANCER 1-gen-2014 Gerardi, C; Floriani, I; Biagioli, E; D'Incalci, M; Fossati, R; Colombo, N
Fsn0503h antibody-mediated blockade of cathepsin S as potential therapeutic strategy for the treatment of solid tumors 1-gen-2013 Vazquez, R; Astorgues-Xerri, L; Cvitkovic, E; Bekradda, M; Fleck, R; Gormley, J; Buick, R; Kerr, P; Raymond, E; D'Incalci, M; Frapolli, R; Riveiro, Me
A dose dense schedule improves antitumor activity of trabectedin in myxoid liposarcoma with type III FUS-CHOP chimera 1-gen-2014 Uboldi, S; Frapolli, R; Bello, E; Brich, S; Bozzi, F; Sanfilippo, R; Casali, Pg; Gronchi, A; Galmarini, Cm; Sousa-Faro, Jmf; Pilotti, S; D'Incalci, M
MIRNA181A-5P EXPRESSION AS A BIOMARKER OF TGFB PATHWAY ACTIVATION ASSOCIATED WITH ONCOLOGIC OUTCOME AND TUMOR DIFFUSION IN HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER 1-gen-2017 Ceppi, L; Palazzi, S; Romualdi, C; Dilorenzo, P; Grassi, T; Biagioli, E; Paracchini, L; Milani, R; Buda, A; D'Incalci, M; Marchini, S; Fruscio, R
In silico rendering of cell cycle progression of erlotinib and gemcitabine treatment in pancreatic cancer cells 1-gen-2015 Lupi, M; Falcetta, F; D'Incalci, M; Ubezio, P
Pharmacokinetic study of trabectedin administered as 24-hour infusion in elderly patients with advanced soft tissue sarcoma (STS) treated according to the TR1US ISG study 1-gen-2016 Ferrari, M; Grosso, F; Grignani, G; Ibrahim, T; Tamberi, S; Marra, D; Marchesi, E; Porcu, L; D'Incalci, M; Zucchetti, M
MIRNA LANDSCAPE IN STAGE I EPITHELIAL OVARIAN CANCER DEFINES THE HISTOTYPE SPECIFICITIES 1-gen-2013 Bignotti, E; Calura, E; Fruscio, R; Paracchini, L; Ravaggi, A; Zanotti, L; Tognon, G; D'Incalci, M; Sartori, E; Pecorelli, S
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1 a 20 di 685
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 4 Contributo in Atti di Convegno ...685
Autore
  • Marcacci, Maurilio180
  • S. Zaffagnini96
  • CIVILINI, EFREM74
  • Chiesa R64
  • KON, ELIZAVETA61
  • VINCIGUERRA, PAOLO58
  • ASSELTA, ROSANNA54
  • DUGA, STEFANO51
  • Melissano G50
  • Tenchini ML39
Data di pubblicazione
  • 2010 - 2020346
  • 2000 - 2009279
  • 1990 - 199949
  • 1980 - 198911
Editore
  • s.n109
  • sn21
  • Springer4
  • AMER SOC CLINICAL ONCOLOGY, 2318 ...3
  • IMECHE2
  • ISAKOS2
  • Oxford University Press2
  • s.n.2
  • Societá Italiana di Ortopedia e T...2
  • 5th Biennal ISAKOS Congress1
Rivista
  • ANNALS OF ONCOLOGY23
  • JOURNAL OF CLINICAL ONCOLOGY21
  • GASTROENTEROLOGY20
  • EUROPEAN JOURNAL OF CANCER13
  • JOURNAL OF CROHN'S AND COLITIS10
  • KNEE SURGERY, SPORTS TRAUMATOLOGY...10
  • NEURO-ONCOLOGY10
  • INTERNATIONAL JOURNAL OF GYNECOLO...7
  • CANCER RESEARCH6
  • ITALIAN JOURNAL OF VASCULAR AND E...6
Keyword
  • .23
  • acl reconstruction3
  • autologous chondrocyte transplant...2
  • Cartilage Repair2
  • Lateral Collagen Meniscus Implant2
  • laxities2
  • Medial Collagen Meniscus Implant2
  • menisco2
  • Nano-Composite Biomaterial2
  • navigation system2
Lingua
  • eng346
  • ita116
  • fre7
  • und2
Accesso al fulltext
  • no fulltext658
  • reserved27